Drug intelligence / Profile preview

chlorambucil + prednisone

Development stage
Unknown
Lead developer
GSK
Modality
Small Molecules
Administration
Oral
01

Overview

The combination of chlorambucil and prednisone is a chemotherapy regimen used primarily for treating various types of cancer, particularly hematological malignancies. This combination leverages the complementary mechanisms of these two drugs to achieve better therapeutic outcomes than either drug alone.

Composition and Mechanism

Chlorambucil is an alkylating agent that works by forming covalent bonds with nucleic acids, disrupting DNA strands and suppressing antibody production. It belongs to the nitrogen mustard family of chemotherapy drugs and is cell cycle non-specific, being most effective during the resting phase of cell division.

Prednisone is a corticosteroid with anti-inflammatory and immunosuppressive properties. When combined with chlorambucil, it enhances the overall efficacy of the treatment regimen.

Medical Uses

The chlorambucil + prednisone combination is primarily used to treat:

  • Chronic lymphocytic leukemia (CLL)
  • Non-Hodgkin's lymphoma
  • Hodgkin's disease
  • Waldenström's macroglobulinemia

In veterinary medicine, this combination is also used to treat lymphoma, inflammatory bowel disease, and immune-mediated disorders in dogs and cats.

Dosage and Administration

The dosage regimen varies depending on the specific condition being treated:

  • For Waldenström's macroglobulinemia: chlorambucil (8 mg/m² daily) and prednisone (40 mg/m² daily) for 10 days every 6 weeks
  • For chronic lymphocytic leukemia and non-Hodgkin's lymphoma: dosages are typically adjusted based on clinical response and hematologic parameters

The medication is usually administered orally, with chlorambucil often taken on an empty stomach.

Side Effects

Common side effects include:

  • Hematologic effects: lymphopenia, neutropenia, and potential bone marrow suppression
  • Gastrointestinal symptoms: nausea, vomiting (though less severe than with some other chemotherapy regimens)
  • Increased susceptibility to infections due to immunosuppression

More serious but less common side effects include:

  • Seizures (particularly with high doses)
  • Irreversible bone marrow damage (with high cumulative doses)

Advantages Over Other Regimens

The chlorambucil + prednisone combination is often preferred over more aggressive chemotherapy regimens like MOPP (mechlorethamine, vincristine, procarbazine, prednisone) because it causes less severe side effects such as nausea, vomiting, hair loss, and neuropathy, which can improve patient compliance.

Other names
ChlVPP
02

Targets

Beyond the preview

Go deeper on chlorambucil + prednisone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chlorambucil + prednisone.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call